Retinopathy of Prematurity

Network meta-analysis compares anti-VEGF agents/doses vs laser for ROP

The findings from a recent network meta-analysis that compared different agents and doses of anti-vascular endothelial growth factors (anti-VEGF) vs laser photocoagulation (LPC) for treatment of retinopathy of prematurity (ROP) suggest that low doses of the drugs retain efficacy and may reduce ocular and systemic undesired events. Further clinical trials...